FDA: EUAs for COVID-19 Lab Tests Will Continue after PHE Ends
Agency says it will continue to have authority to clear new lab tests and other COVID-19 products on an emergency basis even after the PHE ends.
FDA-nir
Subscribe today for access to
Articles and Reports
Empowered Dx in Hot Water with FDA Again Over COVID-19 Test Kits
At the end of 2022, the agency sent a new warning letter to Empowered for unauthorized distribution of COVID-19 test kits.
FDA Tightens the Screws on EUA Review of COVID-19 Tests
The agency recently announced subtle but significant changes to its policies governing review of new lab tests for COVID-19.
FDA Lowers Risk Classifications For Bone Marrow, Diabetes Diagnostic Tests
...
Already a member? Log in here
Lab Execs Air Concerns Over FDA Regulation of LDTs
...
Already a member? Log in here
Labs Urged to Coordinate With CDC on Ebola Testing
...
Already a member? Log in here
FDA to Hold Workshop on LDTs
...
Already a member? Log in here
Lab Sector Goes to Big Legal Guns in Grapple With FDA Over Test Regulation
...
Already a member? Log in here
CMS Releases New CLIA-Waived Tests, Billing Codes
...
Already a member? Log in here
EBOLA Continues to Warrant Attention From Labs
...
Already a member? Log in here
ACLA Issues White Paper Arguing Against FDA Regulation of LDT
...
Already a member? Log in here
- « Previous
- 1
- …
- 14
- 15
- 16